ľ¹Ï¸£ÀûÓ°ÊÓ

Biography

Ulrich Rothbauer is Professor of Pharmaceutical Biotechnology at the ľ¹Ï¸£ÀûÓ°ÊÓ of Tübingen. Over the past two decades he has pioneered the development and use of nanobodies for proteomics, high-resolution microscopy, and in vivo imaging.

His current research focuses on (i) the development of chromobodies—fluorescent biosensors based on nanobodies—that enable real-time visualization and quantification of endogenous proteins in living cells and (ii) the engineering and functionalization of nanobodies as novel theranostics for diagnostic (pre)clinical PET/MRI imaging and functional modulation of immune cells in the context of tumor-related immunotherapies. His vision is to bridge the gap between cell biology and translational approaches, thereby developing new strategies for phenotypic screening, in vivo diagnostics, and targeted therapy.

Dr. Rothbauer has also been involved in translating nanobody technologies into practical applications and is the founder of ChromoTek GmbH (now part of Proteintech), a biotech company specializing in nanobody-based research reagents.